Center-Authored Papers

Filters: Author is Arnold, Kathryn B  [Clear All Filters]
2008
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM.  2008.  Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 167(8):925-34. Abstract
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
2009
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract
2010
Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM.  2010.  Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.. Clinical trials (London, England). 7(1):90-9. Abstract
Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM.  2010.  Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.. American journal of epidemiology. 172(5):566-77. Abstract
2011
Schenk JM, Kristal AR, Arnold KB, Tangen CM, Neuhouser ML, Lin DW, White E, Thompson IM.  2011.  Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.. American journal of epidemiology. 173(12):1419-28. Abstract
2012
Parsons KJ, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, Kristal AR.  2012.  Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia.. European urology. Abstract
Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K et al..  2012.  Moving a randomized clinical trial into an observational cohort.. Clinical trials (London, England). Abstract
2014
Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S et al..  2014.  Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2015
Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia SM, Kristal AR.  2015.  Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA oncology. 1(3):342-9. Abstract
Cassano PA, Guertin KA, Kristal AR, Ritchie KA, Bertoia ML, Arnold KB, Crowley JJ, Hartline JA, Goodman PJ, Tangen CM et al..  2015.  A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.. Respiratory research. 16(1):35. Abstract
2016
Goodman PJ, Tangen CM, Darke AK, Arnold KB, Hartline JA, Yee M, Anderson K, Caban-Holt A, Christen WG, Cassano PA et al..  2016.  Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.. Trials. 17:400. Abstract
Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline JA, Goodman PJ, Minasian LM, Lippman SM, Klein E, Cassano PA.  2016.  Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.. Free radical biology & medicine. 95:349-356. Abstract
Kulac I, Gumuskaya B, Drake CG, Gonzalez B, Arnold KB, Goodman PJ, Kristal AR, Lucia SM, Thompson IM, Isaacs WB et al..  2016.  Peripheral zone inflammation is not strongly associated with lower urinary tract symptom incidence and progression in the placebo arm of the prostate cancer prevention trial .. The Prostate. Abstract
Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB et al..  2016.  Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients.. Future oncology (London, England). Abstract